SoCalBio Mast

SoCalBio Weekly Update

Past Weekly Updates
Thanks to Lead SoCalBio Sponsors
 
 
  
Looking for Legal Help with IP, Business, Labor and Immigration
Matters?
 
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business
 
 
Newest Addition
 
Diversified Alarm Services

 For security applications including access control, video surveillance, burglar and fire alarms with 24 hour UL monitoring. For more information, contact Daniel Johnson at 800-252-7652 or send e-mail to: alarmla@aol.com
Recommended Events
 
Coming on 
October 26
 
 BioEngineering Insights 2009
 
------------------------------ -------

Register Now
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Editor: Ahmed A. Enany
President & CEO
Southern California Biomedical 
Council (SoCalBio)
August 17, 2009

Send to a Colleague

 
RSVP Now (Only 4 Weeks Away)
Keynote Speaker 
Industry Veteran Francois Nader Will Keynote the SoCalBio Investor & Partnership Conference
Dr. Nader has served as President and Chief Executive Officer of NPS Pharmaceuticals since March 2008. Before joining NPS, Dr. Nader was a venture partner at Care Capital, LLC and Chief Medical Officer of its Clinical Development Capital unit from July 2005, to June 2006. From 2000 to July 2005, he served as Senior Vice President, Integrated Healthcare Markets and Senior Vice-President, North America Medical and Regulatory Affairs with Aventis Pharmaceuticals. He also held similar positions at Hoechst Marion Roussel and served as Head of Global Commercial Operations at the Pasteur Vaccines division of Rhone-Poulenc. Francois Nader received a French State Doctorate in Medicine from St. Joseph University and a Physician Executive M.B.A. from the University of Tennessee... RSVP now to attend the conference
Apply Now to Make a Presentation at the SoCalBio Investor/Partnership Conference
Is your firm an innovative advanced medical technology or biotech company interested in raising capital, partnering your products or technologies, or initiating strategic alliances? If so, apply now for a company presentation slot during the 11th SoCalBio Investor and Partnership Conference on Sep. 17, 2009 at the Loews Hotel in Santa Monica. Send an executive summary

Upcoming SoCalBio Business Mixers

  • August 27, 7:00 - 9:30 am
    • SoCalBio Networking Forum in Irvine (UCI University Club)

Focus: Meeting Pricing and Reimbursement Challenges for Device Companies in a Changing Healthcare System ... More Info

  • September 30, 4:00 - 7:00 pm
    • SoCalBio Networking Forum in Ventura County (Westlake Village Inn)

Focus: Innovation and Protecting Your Intellectual Property in a Changing Patent Regime ... More Info

New SoCalBio Members

K-Space (Beverly Hills)

Designs and manufactures accessory devices and software for MRI and fMRI ... Learn more
 
Biological Test Center (Irvine, CA)
Preclinical contract research organization. For more info, contact Dr. Stacy Pritt at stacy.pritt@bbraun.com
 
Expansion

Dandreon Plans a Prostate Cancer Vaccine Manufacturing Facility in Seal Beach

Encouraged by the prospects of FDA Approval of its prostate cancer vaccine, PROVENGE, the Seattle-based Dandreon planed new manufacturing facilites in a number of locations including the Greater Los Angeles area. Dendreon just signed a lease agreement on 184,000 square feet of existing space at the Pacific Gateway Business Park in Seal Beach. "We are pleased to announce that we are expanding our manufacturing capacity with the addition of two new facilities in Atlanta and Los Angeles," said Dendreon CEO Mitchell H. Gold (photo right) in a press release.... Learn more
Spin-off

Beckman Coulter Announces the Creation of Beckman Coulter Genomics

The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities. It will based in Beverly, Massachusetts ... Read more
Clinical Studies

 AVANIR Announces Positive Phase III Study 
Results for Zenvia

Zenvia (dextromethorphan/quinidine) is a combination of two well-characterized compounds: the therapeutically active ingredient dextromethorphan and the enzyme inhibitor quinidine, which serves to increase the bioavailability of dextromethorphan. This first-in-class drug candidate is believed to help regulate excitatory neurotransmission in two ways: through pre-synaptic inhibition of glutamate release via sigma-1 receptor agonist activity and through postsynaptic glutamate response modulation via uncompetitive, low-affinity NMDA antagonist activity ... Read more
New Products

Reverse Medical Corporation of Irvine Receives US FDA 510k Clearance for the ReCruit Microcatheter for Use Including Neuro Interventional Procedures

The ReCruit Microcatheter is intended to retrieve intravascular foreign objects during interventional radiology procedures including from the Neurovasculature ... Read more
 
The Los Angeles-based Mind Gamz Brings Therapy to the iPhone with the Game Think Like a Shrink
 
"Think Like a Shrink is the first true interactive therapy game with a narrative structure," says Mind Gamz Director Glennis McClellan, "prior to this, psychology and mental health games consisted mostly of personality tests and quizzes. With Think Like a Shrink, players are invited to conduct their own therapy sessions." McClellan continued ... Read more
Acquisitions

 The Woodland Hills-Based Migami, Inc. Announces Signing of Letter of Intent for Business Combination with BBV Vietnam S.E.A. Acquisition Corp.

"We are delighted to have entered into a Letter of Intent with BBV Vietnam S.E.A. Acquisition Corp. and are very much looking forward to working with BBV and its industry contacts in order to help Migami continue Migami's development and achieve its strategic business goals as rapidly as possible," states John Park, Chairman and CEO of Migami.... Read more
Hot Jobs

For more jobs, sign up to access SoCalBio's LinkedIn Page

About SoCalBio

SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio